Physicians should consider a myasthenia gravis diagnosis in patients who exhibit symptoms such as dysphagia (difficulty swallowing), dysphonia (difficulty speaking),…
Articles by Iqra Mumal, MSc
Treatment with Lemtrada (alemtuzumab), approved for relapsing-remitting multiple sclerosis, may increase the risk of patients developing other autoimmune…
A new, modified method for removal of the thymus (thymectomy) in patients with myasthenia gravis can help achieve complete…
A Phase 1 study in healthy volunteers shows that argenx’s efgartigimod (ARGX-113) holds potential as a safe and effective…
There are a number of unanswered questions for researchers and clinicians involved with myasthenia gravis (MG), from understanding the…
Concentric needle-jitter is more accurate in diagnosing myasthenia gravis (MG) than repetitive nerve stimulation or acetylcholine receptor antibody positivity,…
Patients with myasthenia gravis (MG) have higher levels of a chemical modification — known as DNA methylation — on…
Expanded use of the U.S. Food and Drug Administration-approved therapy Soliris (eculizumab) to treat myasthenia gravis (MG) could lead to a…
Researchers have determined that video-assisted thoracic surgery to remove a thymoma — a tumor in the thymus — is a…
The results of a Phase 3 clinical trial are challenging the long-held notion that the same thymus gland mechanism is…